SC
GBT

Shay Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Shay Capital’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,800
Closed -$463K – 464
2022
Q3 		$463K Buy
+6,800
New +$375K 0.1% 158

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Shay Capital's GBT Position: Q4 2022 in Review

Shay Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 6,800 shares — an estimated $463K sold.

Shay Capital first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $463K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Shay Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Shay Capital sold 6,800 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $463K.
  • Shay Capital first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Shay Capital's Global Blood Therapeutics, Inc. position peaked at $463K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Shay Capital's 13F filing for Q4 2022, filed 14 Feb 2023.